Innovative Therapies Inc. Sustainability Profile
Innovative Therapies Inc., a leading name in the healthcare industry, is headquartered in the United States and operates across various major regions. Founded in [year], the company has established itself as a pioneer in developing advanced therapeutic solutions, focusing on innovative treatments that enhance patient outcomes. With a diverse portfolio of core products and services, Innovative Therapies Inc. stands out for its commitment to research and development, ensuring that its offerings are at the forefront of medical advancements. The company has achieved significant milestones, solidifying its market position as a trusted provider of cutting-edge therapies. Recognised for its contributions to the field, Innovative Therapies Inc. continues to push the boundaries of healthcare, making a meaningful impact on the lives of patients and healthcare professionals alike.
DitchCarbon Score
How does Innovative Therapies Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Innovative Therapies Inc.'s score of 65 is higher than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Innovative Therapies Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Cardinal Health, Inc., which means that any climate commitments or emissions data may be inherited from its parent organisation. As part of its corporate family relationship, Innovative Therapies Inc. aligns with the sustainability initiatives and targets set by Cardinal Health, Inc. This includes participation in various climate-related frameworks such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). However, specific reduction targets or achievements for Innovative Therapies Inc. have not been disclosed. The absence of direct emissions data suggests that Innovative Therapies Inc. is in the early stages of establishing its own climate commitments. The company may benefit from the sustainability strategies and performance metrics cascaded from Cardinal Health, Inc., which is actively engaged in reducing its carbon footprint and enhancing its environmental stewardship. In summary, while Innovative Therapies Inc. does not currently report emissions data or specific reduction targets, it is positioned within a corporate structure that prioritises climate action through the initiatives of its parent company, Cardinal Health, Inc.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2009 | 2010 | 2016 | 2017 | 2018 | 2019 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 148,856,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 212,644,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | 00,000,000 | - | - | - | 00,000,000,000 | 00,000,000,000 |
How Carbon Intensive is Innovative Therapies Inc.'s Industry?
How Carbon Intensive is Innovative Therapies Inc.'s Location?
Innovative Therapies Inc.'s Scope 3 Categories Breakdown
Innovative Therapies Inc.'s Scope 3 emissions, which increased by 5% last year and increased significantly since 2018, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 93% of Scope 3 emissions.
Top Scope 3 Categories
Innovative Therapies Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Innovative Therapies Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
